5-FLUOROURACIL AND METHOTREXATE COMBINATION CHEMOTHERAPY - THE EFFECT OF DRUG SCHEDULING

被引:43
作者
MULDER, JH [1 ]
SMINK, T [1 ]
VANPUTTEN, M [1 ]
机构
[1] ROTTERDAM RADIO THERAPEUT INST,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 07期
关键词
D O I
10.1016/0014-2964(81)90240-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:831 / 837
页数:7
相关论文
共 26 条
[1]  
BAREHAM CR, 1974, CANCER RES, V34, P571
[2]  
BERTINO JR, 1979, CANCER RES, V39, P293
[3]  
BERTINO JR, 1977, CANCER RES, V37, P327
[4]   FLUOROPYRIMIDINE-INDUCED ANTAGONISM TO FREE AND TIGHTLY BOUND METHOTREXATE - SUPPRESSION OF [C-14] FORMATE INCORPORATION INTO RNA AND PROTEIN [J].
BOWEN, D ;
FOLSCH, E ;
GUERNSEY, LA .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (07) :893-899
[5]   THERAPEUTIC CONSEQUENCES OF ANTITUMOUR DRUG INTERACTIONS - METHOTREXATE AND 5-FLUOROURACIL IN CHEMOTHERAPY OF C3H MICE WITH TRANSPLANTED MAMMARY ADENOCARCINOMA [J].
BROWN, I ;
WARD, HWC .
CANCER LETTERS, 1978, 5 (05) :291-297
[6]   ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].
CADMAN, E ;
HEIMER, R ;
DAVIS, L .
SCIENCE, 1979, 205 (4411) :1135-1137
[7]   COMBINED EFFECTS OF METHOTREXATE AND 5-FLUOROPYRIMIDINE ON HUMAN-BREAST CANCER-CELLS IN SERUM-FREE CULTURE [J].
DONEHOWER, RC ;
ALLEGRA, JC ;
LIPPMAN, ME ;
CHABNER, BA .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) :655-661
[8]  
FRIEDMAN MA, 1978, CANCER CHEMOTH PHARM, V1, P77
[9]  
HEPPNER GH, 1977, CANCER RES, V37, P4580
[10]  
KLINE I, 1966, CANCER RES, V26, P848